Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Stomach Neoplasms × Thalidomide × Clear all

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Multiple Myeloma 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Bismuth 5 Oxaliplatin 4 Esomeprazole 4 Amoxicillin 4 apatinib 3 Tetracycline 3 Irinotecan 3 Fluorouracil 3 Clarithromycin 3 fish oil triglycerides 2 Leucovorin 2 Indocyanine Green 2 Furazolidone 2 sintilimab 1 potassium oxonate 1 lenvatinib 1 iron isomaltoside 1000 1 gimeracil 1 ferric carboxymaltose 1 doxifluridine 1 alanylglutamine 1 Water 1 Trastuzumab 1 Tranexamic Acid 1 Tobacco Use Cessation Devices 1 Thalidomide 1 Tegafur 1 Surgical Procedures, Operative 1 Simethicone 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02401971 2015-03-30

ITAGC

Zhengzhou University

Phase 4 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡